Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD of NGM BIOPHARMACEUTICALS INC from Q4 2021 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
NGM BIOPHARMACEUTICALS INC quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and change rate from Q4 2021 to Q3 2023.
  • NGM BIOPHARMACEUTICALS INC Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending 30 Sep 2023 was $3K.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Change (%)

NGM BIOPHARMACEUTICALS INC Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2023 $3K 30 Sep 2023 10-Q 02 Nov 2023
Q2 2023 $17K 30 Jun 2023 10-Q 03 Aug 2023
Q1 2023 $38K 31 Mar 2023 10-Q 04 May 2023
Q4 2022 $70K -$41K -36.9% 31 Dec 2022 10-K 28 Feb 2023
Q4 2021 $111K 31 Dec 2021 10-Q 03 Nov 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.